investorscraft@gmail.com

Intrinsic ValueTri Chemical Laboratories Inc. (4369.T)

Previous Close¥3,300.00
Intrinsic Value
Upside potential
Previous Close
¥3,300.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Tri Chemical Laboratories Inc. operates in the specialty chemicals sector, focusing on high-purity precursors essential for semiconductors, optical fibers, solar cells, and compound semiconductors. The company’s revenue model is built on supplying niche chemical solutions to advanced manufacturing industries, complemented by a secondary business in specialized containers for high-purity and high-pressure applications. Its product portfolio includes catalysts, reagents, and precision storage solutions, catering to stringent industry requirements. Positioned as a critical supplier in the semiconductor and renewable energy supply chains, Tri Chemical Laboratories benefits from technological advancements driving demand for high-performance materials. The company’s expertise in ultra-pure chemicals and tailored packaging solutions provides a competitive edge in markets where quality and reliability are paramount. With a strong foothold in Japan and potential expansion in global high-tech manufacturing hubs, it maintains a defensible niche amid growing demand for specialized chemical inputs.

Revenue Profitability And Efficiency

Tri Chemical Laboratories reported revenue of JPY 18.9 billion for FY2025, with net income reaching JPY 4.96 billion, reflecting a robust net margin of approximately 26.2%. The company’s operating cash flow stood at JPY 3.68 billion, though capital expenditures of JPY 3.07 billion indicate significant reinvestment. This balance suggests disciplined growth spending while maintaining profitability.

Earnings Power And Capital Efficiency

The company’s diluted EPS of JPY 152.69 underscores strong earnings power, supported by its niche market focus. With a cash position of JPY 9.44 billion against total debt of JPY 1.78 billion, Tri Chemical Laboratories demonstrates efficient capital management, leveraging its balance sheet to fund operations and growth without excessive leverage.

Balance Sheet And Financial Health

Tri Chemical Laboratories maintains a solid financial position, with JPY 9.44 billion in cash and equivalents and modest debt of JPY 1.78 billion. This low leverage ratio, combined with healthy operating cash flow, positions the company to navigate cyclical industry demands while supporting R&D and capacity expansions.

Growth Trends And Dividend Policy

The company’s growth is tied to semiconductor and renewable energy sector trends, with potential upside from global supply chain diversification. A dividend of JPY 35 per share reflects a commitment to shareholder returns, though the payout ratio remains conservative, aligning with reinvestment needs for future expansion.

Valuation And Market Expectations

With a market cap of JPY 90.4 billion and a beta of 1.042, Tri Chemical Laboratories trades with moderate volatility, reflecting its niche but cyclical exposure. Investors likely price in sustained demand for specialty chemicals, though sector-wide capacity shifts could influence valuations.

Strategic Advantages And Outlook

Tri Chemical Laboratories’ strategic advantage lies in its technical expertise and reliability as a supplier to high-growth industries. The outlook remains positive, driven by secular trends in semiconductor and clean energy adoption, though competitive pressures and input cost volatility warrant monitoring.

Sources

Company filings, market data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount